Please ensure Javascript is enabled for purposes of website accessibility

Got $1,000 to Invest? 3 Stocks That Will Make You Richer in 2021

By Keith Speights - Jan 21, 2021 at 6:05AM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Here's how they'll do it.

Some stocks simply have the "it" factor. They stand apart from the crowd because of their distinct competitive advantages in a fast-growing market.

These kinds of stocks become huge winners over the long run, and can also deliver strong returns in a short period of time. You don't need a massive upfront investment to profit from them. If you've got $1,000 to invest, here are three such stocks that will likely make you richer in 2021. 

Young woman smiling while holding her smartphone with images of dollar signs around the phone

Image source: Getty Images.

1. Fiverr

Fiverr (FVRR 7.32%) was sizzling-hot last year, with its shares skyrocketing 730%. One key reason behind this tremendous performance was the COVID-19 pandemic. The rise of working from home, lockdowns, and job displacement spurred growth in the freelancing industry.

Freelancing has become increasingly popular over the last decade. Fiverr saw the trend developing early on and developed a software platform that connected freelancers with companies seeking digital services. It takes a cut from both the seller and the buyer of these services.

Fiverr's key competitive advantage is that it removes the friction for both sides. Freelancers don't have to bid or negotiate to win deals. Buyers get transparency on pricing, timing, and specific deliverables. Fiverr calls this approach "service-as-a-product (SaaP)."

The market potential is huge -- Fiverr pegs its addressable U.S. market at $115 billion per year. Most freelancing deals are still conducted offline. With the economy potentially rebounding this year as pandemic worries subside, Fiverr should be on track to generate impressive gains again in 2021.

2. The Trade Desk

There was good news and bad news last year for The Trade Desk (TTD 6.59%) from the pandemic. Some advertisers reduced their spending. This hurt The Trade Desk, which runs a leading software platform for buying digital ads. However, the company still managed to gain market share -- a definite plus. Investors focused more on the positives for The Trade Desk than the negatives, with the stock nearly tripling in 2020.

The continued roll-outs of COVID-19 vaccines should help the economy recover as life returns to a semblance of normality. This, in turn, should increase advertisers' confidence and spur them to loosen their purse strings. The Trade Desk is well-positioned to profit.

It's also launching one of its biggest system upgrades ever in 2021. The last time the company had a major platform upgrade in 2018, its market share soared. History could very well repeat itself this year.

The Trade Desk's long-term prospects remain very bright. Connected TV (CTV) continues to make major inroads, which is increasingly attracting advertisers. It's not surprising that The Trade Desk CEO Jeff Green stated in November that "there's no place in our business that we're more excited about than in CTV." He has a good reason to be excited, and so do investors.

3. Guardant Health

In comparison to Fiverr and The Trade Desk, Guardant Health (GH 10.78%) might seem like a laggard. The healthcare stock delivered a return of "only" 103% last year. But Guardant Health's momentum is just cranking up.

The company is a leader in liquid biopsies, which analyze tumors in nonsolid tissues, like blood. Its Guardant360 CDx is the first liquid biopsy approved by the U.S. Food and Drug Administration for comprehensive tumor mutation profiling for all solid cancers. The company also markets two other liquid biopsy products.

Look for all of Guardant Health's current products to enjoy strong sales growth in 2021. They've only begun to tap the estimated $6 billion annual U.S. market. 

But Guardant Health has a much bigger opportunity with recurrence monitoring and early stage cancer detection, a market projected to top $65 billion annually. The company plans to launch its first recurrence monitoring product, Guardant Reveal, in the first quarter of this year. With a market cap of around $16 billion, Guardant Health should have a lot of room to run -- making investors richer in 2021 and beyond.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Guardant Health, Inc. Stock Quote
Guardant Health, Inc.
$42.67 (10.78%) $4.15
The Trade Desk Stock Quote
The Trade Desk
$52.26 (6.59%) $3.23
Fiverr International Ltd. Stock Quote
Fiverr International Ltd.
$42.69 (7.32%) $2.91

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning service.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 05/27/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.